Abstract
The therapeutic approach to mucous membrane pemphigoid is site specific, with the goal of preserving function for patients with chronic and treatment-resistant disease. The involvement of certain mucosal sites (ie, ocular, laryngeal, esophageal, nasopharyngeal, and anogenital) is high risk and warrants more aggressive intervention. Control of the disease must be balanced with minimizing the sequelae of long-term exposure to systemic glucocorticosteroids and/or other immunosuppressives. Timely interventions and multidisciplinary management are essential in preventing disability.
Original language | English (US) |
---|---|
Pages (from-to) | 637-641 |
Number of pages | 5 |
Journal | Dermatologic Clinics |
Volume | 29 |
Issue number | 4 |
DOIs | |
State | Published - Oct 1 2011 |
Keywords
- Glucocorticosteroids
- Immunosuppressives
- Interdisciplinary
- Mucosal sites
ASJC Scopus subject areas
- Dermatology